Menu

• Ask a Health Expert about ACUTE MYELOID LEUKAEMIA
• Post Your Side Effect related to ACUTE MYELOID LEUKAEMIA
• ACUTE MYELOID LEUKAEMIA and FDA Warnings
• ACUTE MYELOID LEUKAEMIA in Patients Wiki
• Report ACUTE MYELOID LEUKAEMIA in Drug Side Effect Survey

ACUTE MYELOID LEUKAEMIA side effect

What is ACUTE MYELOID LEUKAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Mabthera Side Effects Report #5528284-7
Health Professional from UNITED KINGDOM reported MABTHERA problem on Nov 16, 2007. Male patient was diagnosed with lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with ADRIAMYCIN PFS, ADRIAMYCIN PFS, ALKERAN, ETOPOSIDE, BICNU, ARACYTINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Januvia Side Effects Report #5647157-2
JANUVIA problem was reported by a Physician from UNITED STATES on Feb 21, 2008. Male patient, 59 years of age, was diagnosed with diabetes mellitus and was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . JANUVIA dosage: unknown. During the same period patient was treated with METFORMIN, LIPITOR, CAPOTEN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5651480-5
Consumer or non-health professional from UNITED KINGDOM reported RITUXAN problem on Feb 25, 2008. Female patient, 75 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died.

Fludara Side Effects Report #5652910-5
FLUDARA problem was reported by a Physician from KOREA, REPUBLIC OF on Feb 28, 2008. Male patient, 67 years of age, weighting 90.39 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, dyspnoea, haematuria, hyperbilirubinaemia, pyrexia, . FLUDARA dosage: TOTAL DAILY DOSE: 38 MG. During the same period patient was treated with CYTARABINE, IDARUBICIN, NASEA, TAZOCIN. Patient died on 02/19/2008.


Januvia Side Effects Report #5655370-3
Physician from UNITED STATES reported JANUVIA problem on Feb 21, 2008. Male patient, 59 years of age, was diagnosed with diabetes mellitus and was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . JANUVIA dosage: unknown. During the same period patient was treated with METFORMIN, LIPITOR, CAPOTEN. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5661552-7
EXJADE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2008. Male patient, 78 years of age, weighting 145.0 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, haemoglobin decreased, . EXJADE dosage: 1000 MG, QD. Patient died on 11/20/2007.

Valproic Side Effects Report #5663407-0
Physician from UNITED STATES reported VALPROIC ACID SYRUP problem on Feb 29, 2008. Female patient, child 2 years of age, was diagnosed with epilepsy and was treated with VALPROIC ACID SYRUP. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, anorexia, blood lactate dehydrogenase increased, lethargy, petit mal epilepsy, pyrexia, skin discolouration, splenomegaly, . VALPROIC ACID SYRUP dosage: 675 MG; QD; PO. During the same period patient was treated with PHENOBARBITAL, ZONISAMIDE. Patient was hospitalized. Patient recovered.

Cap Side Effects Report #5663718-9
CAP VORINOSTAT UNK problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2008. Male patient, 64 years of age, weighting 264.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blood magnesium increased, condition aggravated, gastrooesophageal reflux disease, haematemesis, hypokalaemia, nausea, vomiting, . CAP VORINOSTAT UNK dosage: 400 MG/DAILY/PO. During the same period patient was treated with INJ DECITABINE UNK, DIFLUCAN, EUCERIN CREME, EXJADE, HYDREA, IMODIUM. Patient was hospitalized and became disabled. Patient recovered.

Revlimid Side Effects Report #5668558-2
Physician from UNITED STATES reported REVLIMID problem on Mar 03, 2008. Male patient, 86 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, myelodysplastic syndrome, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/14/2008.


Revlimid Side Effects Report #5668665-4
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 04, 2008. Female patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant neoplasm progression, pneumonia, . REVLIMID dosage: 10 MG, QD, ORAL. During the same period patient was treated with ACYCLOVIR, CALCIUM, GABAPENTIN, LEUCOVORIN CALCIUM, PRILOSEC, VORICONAZOLE, OXYCONTIN, COMPAZINE. Patient was hospitalized. Patient died on 10/08/2007.

Gleevec Side Effects Report #5669209-3
Consumer or non-health professional from BRAZIL reported GLEEVEC problem on Mar 07, 2008. Male patient, weighting 220.5 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, asthenia, chromosome analysis abnormal, convulsion, headache, platelet count decreased, therapeutic procedure, . GLEEVEC dosage: 400 MG/D. Patient was hospitalized. Patient recovered.

Neupogen Side Effects Report #5670114-7
NEUPOGEN problem was reported by a Physician from SOUTH AFRICA on Mar 04, 2008. Female patient, 65 years of age, was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blast cell crisis, neutropenic sepsis, . NEUPOGEN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient died.

Isentress Side Effects Report #5671568-2
Health Professional from UNITED STATES reported ISENTRESS problem on Mar 11, 2008. Male patient, 53 years of age, weighting 163.1 lb, was diagnosed with hiv infection, hyperlipidaemia, hypertension, hypogonadism and was treated with ISENTRESS. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, pancytopenia, rash, . ISENTRESS dosage: unknown. During the same period patient was treated with LEXIVA, VIREAD, PRAVACHOL, GEMFIBROZIL, LISINOPRIL, HYDROCHLOROTHIAZIDE, REYATAZ. Patient was hospitalized and became disabled. Patient recovered.

Levaquin Side Effects Report #5674581-4
LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 13, 2008. Female patient, 71 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . LEVAQUIN dosage: unknown. Patient recovered.


Revlimid Side Effects Report #5675861-9
Physician from UNITED STATES reported REVLIMID problem on Mar 12, 2008. Female patient, 69 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, no therapeutic response, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5677233-X
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2008. Male patient was diagnosed with acute myeloid leukaemia, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, confusional state, disease progression, oral candidiasis, oral intake reduced, pancytopenia, weight decreased, . REVLIMID dosage: 5MG DAILY PO. During the same period patient was treated with MORPHINE CONCENTRATE, NYSTATION. Patient died on 03/12/2008.

Etoposide Side Effects Report #5677267-5
Consumer or non-health professional from FRANCE reported ETOPOSIDE problem on Mar 12, 2008. Male patient, child 9 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, gene mutation, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, MITOXANTRONE, AMSACRINE. Patient recovered.

Cyclophosphamide Side Effects Report #5680815-2
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Mar 24, 2008. Female patient, 60 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage iv, acute myeloid leukaemia, palliative care and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, neutropenia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXIMAB, IDARUBICIN, CYTARABINE, ETOPOSIDE, THIOGUANINE. Patient died.

Revlimid Side Effects Report #5680902-9
Physician from UNITED STATES reported REVLIMID problem on Mar 18, 2008. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, malignant neoplasm progression, myelodysplastic syndrome, . REVLIMID dosage: 10-5 MG, DAILY, ORAL, 10 MG, DAILY; ORAL. Patient died on 01/31/2008.


Imuran Side Effects Report #5681019-X
IMURAN problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 51 years of age, was diagnosed with crohn's disease, graft versus host disease and was treated with IMURAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, aspergillosis, bone marrow transplant, graft versus host disease, hemiparesis, leukopenia, transplant failure, . IMURAN dosage: unknown. During the same period patient was treated with REMICADE, SULFSALAZINE. Patient was hospitalized. Patient died on 07/31/2006.

Revlimid Side Effects Report #5683438-4
Health Professional from SPAIN reported REVLIMID problem on Mar 18, 2008. Male patient, 80 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, . REVLIMID dosage: 10 MG, DAILY, ORAL : 5 MG, DAILY, ORAL. Patient died on 01/03/2008.

Prograf Side Effects Report #5688149-7
PROGRAF problem was reported by a Physician from JAPAN on Mar 17, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, leukaemia recurrent, . PROGRAF dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died on 04/01/2005.

Exjade Side Effects Report #5612703-1
Physician from CANADA reported EXJADE problem on Jan 31, 2008. Female patient, 69 years of age, weighting 123.0 lb, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . EXJADE dosage: 1000 MG, DAILY. During the same period patient was treated with ELTROXIN. Patient was hospitalized. Patient died on 07/20/2007.

Sandimmune Side Effects Report #5621809-2
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on Feb 08, 2008. Male patient, 53 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, convulsion, delirium, depressed level of consciousness, reversible posterior leukoencephalopathy syndrome, visual disturbance, . SANDIMMUNE dosage: unknown. Patient died.

Sandimmune Side Effects Report #5621811-0
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on Feb 08, 2008. Male patient, 53 years of age, was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, convulsion, delirium, depressed level of consciousness, reversible posterior leukoencephalopathy syndrome, visual disturbance, . SANDIMMUNE dosage: unknown. Patient died.

Cerezyme Side Effects Report #5625442-8
CEREZYME problem was reported by a Physician from UNITED STATES on Feb 05, 2008. Male patient, 60 years of age, weighting 205.0 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute myeloid leukaemia (in remission), acute myeloid leukaemia recurrent, . CEREZYME dosage: unknown. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5626065-7
Health Professional from SPAIN reported CYCLOPHOSPHAMIDE problem on Feb 11, 2008. Female patient, 60 years of age, was diagnosed with lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARA, RITUXIMAB. Patient died.

Cyclophosphamide Side Effects Report #5626077-3
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from SPAIN on Feb 11, 2008. Female patient, 60 years of age, was diagnosed with lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARA, RITUXIMAB. Patient died.

Velcade Side Effects Report #5626475-8
Physician from FRANCE reported VELCADE problem on Feb 06, 2008. Male patient, 35 years of age, weighting 156.5 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . VELCADE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, IFOSFAMIDE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5627421-3
FLUOROURACIL problem was reported by a Consumer or non-health professional from GREECE on Feb 06, 2008. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . FLUOROURACIL dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE, TAXOL, EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5627962-9
Health Professional from SPAIN reported CYCLOPHOSPHAMIDE problem on Feb 13, 2008. Female patient, 60 years of age, was diagnosed with lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXIMAB. Patient died.

Norvasc Side Effects Report #5628438-5
NORVASC problem was reported by a Physician from JAPAN on Feb 07, 2008. Male patient, 66 years of age, was diagnosed with hypertension and was treated with NORVASC. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, gingival hypertrophy, . NORVASC dosage: DAILY DOSE:5MG-TEXT:TDD:5MG. During the same period patient was treated with MICARDIS, AMARYL, BASEN, ETHYL ICOSAPENTATE. Patient died on 12/11/2007.

Bleomycin Side Effects Report #5630335-6
Health Professional from JAPAN reported BLEOMYCIN problem on Feb 14, 2008. Female patient, 31 years of age, was diagnosed with hodgkin's disease and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . BLEOMYCIN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINBLASTINE SULPHATE, DACARBAZINE. Patient recovered.

Humira Side Effects Report #5631049-9
HUMIRA problem was reported by a Health Professional from SWEDEN on Feb 15, 2008. Male patient, 60 years of age, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . HUMIRA dosage: unknown. During the same period patient was treated with OMEPRAZOL ABCUR, ACETAMINOPHEN, PROPIOMAZINE MALEATE, ZINC SULPHATE, CODEINE PHOSPHATE. Patient was hospitalized. Patient died.

Remicade Side Effects Report #5632832-6
Physician from JAPAN reported REMICADE problem on Feb 12, 2008. Female patient, 21 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, fall, . REMICADE dosage: unknown. During the same period patient was treated with FERROMIA, FLUVOXAMINE MALEATE. Patient recovered.

Rituxan Side Effects Report #5635536-9
RITUXAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient, 75 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with FLUDARABINE, MITOXANTRONE, DEXAMETHASONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died.

Vfend Side Effects Report #5637323-4
Consumer or non-health professional from JAPAN reported VFEND problem on Feb 13, 2008. Female patient, 71 years of age, weighting 143.5 lb, was diagnosed with febrile neutropenia and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, c-reactive protein increased, condition aggravated, . VFEND dosage: unknown. During the same period patient was treated with DIFLUCAN, ALFAROL, GLAKAY, ZANTAC, ULCERLMIN, TANNALBIN, POLYMYXIN B SULPHATE. Patient died on 05/14/2007.

Endoxan Side Effects Report #5638240-6
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2008. Female patient, 62 years of age, was diagnosed with breast cancer and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . ENDOXAN dosage: unknown. During the same period patient was treated with FARMORUBICIN, FLUOROURACIL. Patient died on 11/14/2005.

Revlimid Side Effects Report #5639409-7
Physician from UNITED STATES reported REVLIMID problem on Feb 15, 2008. Female patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disease progression, myelodysplastic syndrome, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 11/18/2007.

Alkeran Side Effects Report #5640806-4
ALKERAN problem was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, 56 years of age, weighting 114.6 lb, was diagnosed with stem cell transplant, peripheral blood stem cell apheresis and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, autosomal chromosome anomaly, . ALKERAN dosage: 200MGM2 PER DAY. During the same period patient was treated with ETOPOSIDE, VINDESINE SULPHATE, PREDNISOLONE, RANIMUSTINE. Patient was hospitalized. Patient died on 07/01/2007.

Fludarabine Side Effects Report #5641655-3
Consumer or non-health professional from SPAIN reported FLUDARABINE problem on Feb 13, 2008. Female patient, 60 years of age, was diagnosed with lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient died.

Velcade Side Effects Report #5641690-5
VELCADE problem was reported by a Physician from FRANCE on Feb 12, 2008. Male patient, 35 years of age, weighting 156.5 lb, was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . VELCADE dosage: 2.79 MG, INTRAVENOUS; 2.84 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5642595-6
Physician from JAPAN reported REMICADE problem on Feb 19, 2008. Female patient, weighting 101.4 lb, was diagnosed with crohn's disease, iron deficiency anaemia, depression and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, dizziness, fall, . REMICADE dosage: unknown. During the same period patient was treated with FERROMIA, FLUVOXAMINE MALEATE. Patient recovered.

Revlimid Side Effects Report #5644138-X
REVLIMID problem was reported by a Physician from UNITED STATES on Dec 24, 2007. Female patient, 70 years of age, weighting 125.0 lb, was diagnosed with acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, lung neoplasm malignant, malignant neoplasm progression, melanoma recurrent, metastatic malignant melanoma, pericardial effusion, pleural effusion, pulmonary embolism, . REVLIMID dosage: 25 MG, OD, ORAL; 25 MG, 1 IN 1 D,ORAL; 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VITAMIN, PRILOSEC, LASIX, LEXAPRO, ZETIA, SYNTHROID. Patient was hospitalized. Patient died on 11/05/2007.

Ifomide Side Effects Report #5579038-7
Consumer or non-health professional from UNITED STATES reported IFOMIDE problem on Dec 21, 2007. Male patient, 46 years of age, was diagnosed with testicular germ cell cancer and was treated with IFOMIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, disseminated intravascular coagulation, . IFOMIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, PACLITAXEL, IRINOTECAN, NEDAPLATIN. Patient died on 12/18/2004.

Betaferon Side Effects Report #5581504-5
BETAFERON problem was reported by a Health Professional from FRANCE on Dec 19, 2007. Female patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with BETAFERON. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . BETAFERON dosage: unknown. During the same period patient was treated with ENDOXAN, NOVANTRONE, METHOTREXATE, PURINETHOL. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5581697-X
Physician from UNITED KINGDOM reported TRASTUZUMAB problem on Dec 21, 2007. Female patient, weighting 205.9 lb, was diagnosed with breast cancer and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . TRASTUZUMAB dosage: 8 MG/M2, SINGLE. During the same period patient was treated with CAPECITABINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, DOCETAXEL, HYDROCODONE BITARTRATE, EXEMESTANE. Patient recovered.

Endoxan Side Effects Report #5582706-4
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2007. Female patient, child 11 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, EPIRUBICIN. Patient recovered.

Endoxan Side Effects Report #5582789-1
Physician from UNITED STATES reported ENDOXAN problem on Dec 28, 2007. Male patient, child 4 years of age, was diagnosed with burkitt's lymphoma, bone marrow conditioning regimen and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . ENDOXAN dosage: 1 FORM = 9 G/M2; 60MG/M2 ADMINISTERED FOR BONE MARROW CONDITIONG.. During the same period patient was treated with ETOPOSIDE, EPIRUBICIN, MITOXANTRONE, IDARUBICIN. Patient died.

Mylotarg Side Effects Report #5583086-0
MYLOTARG problem was reported by a Physician from JAPAN on Dec 26, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, c-reactive protein increased, fungaemia, hepatic function abnormal, infusion related reaction, malignant neoplasm progression, neutropenia, platelet count decreased, sepsis, . MYLOTARG dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, GASTER. Patient recovered.

Mabthera Side Effects Report #5583625-X
Health Professional from UNITED KINGDOM reported MABTHERA problem on Dec 24, 2007. Female patient, 60 years of age, was diagnosed with b-cell lymphoma, acute myeloid leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, . MABTHERA dosage: 375 MG/M2, UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, IDARUBICIN, CYTARABINE, ETOPOSIDE, THIOGUANINE. Patient died.